HERTAB LAPATINIB TABLETS

Get a Price/Quote

HERTAB LAPATINIB TABLETS Specification

Indication
Breast cancer, cancer treatment

Dosage Form
Tablets

Salt Composition
Lapatinib

Feature
Targeted therapy, used for HER2 positive breast cancer

Ingredients
Lapatinib

Application
Pharmaceutical, oncology

Physical Color/Texture
Yellow film coated tablets

Storage Instructions
Store below 30C, protect from moisture

Shelf Life
24 months

Pack Size
30 Tablets per box

Route of Administration
Oral

Prescription
Prescription only medicine (Rx)

Brand Name
Hertab

Packaging Type
Box

Strength
250 mg

Marketed By
Hetero Healthcare

Therapeutic Class
Antineoplastic agent

HERTAB LAPATINIB TABLETS Trade Information

Packaging Details
PACK OF 150 TABLETS

Main Domestic Market
All India

About HERTAB LAPATINIB TABLETS

Hertab

Specifications:-

Brand Name: HERTAB
Content: Lapatinib
Strength: 250 Mg
Form : Tablets
Packing: 150tablets
Manufactured By: Hetero

Note :- HERTAB Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.............

Targeted Cancer Therapy

HERTAB Lapatinib Tablets are recognized for their targeted mechanism, offering a tailored approach for HER2-positive breast cancer. This precision helps concentrate the treatment effect where it is needed most, potentially reducing side effects and improving patient response compared to broader therapies.

User-Friendly Oral Dosage

Each tablet is intended for oral use, allowing for convenient administration at home or in clinical settings. The compact packaginga box of 30 film-coated, yellow tabletsfacilitates easy adherence to prescribed regimens, contributing to smoother experiences during complex cancer treatments.

Quality and Safety Assured

Manufactured by Hetero Healthcare, HERTAB maintains strict quality standards. With a recommended storage temperature below 30C and robust moisture protection, the product ensures stability throughout its 24-month shelf life, supporting reliable efficacy for patients and healthcare providers.

FAQs of HERTAB LAPATINIB TABLETS:

Q: How should HERTAB Lapatinib Tablets be taken for optimal results?

A: HERTAB Lapatinib Tablets should be taken orally as directed by your physician. Follow the prescribed dosage and schedule closely, and swallow the tablets whole with water. Consistency in timing and adherence to medical instructions are essential for achieving the best possible treatment outcomes.

Q: What is the primary medical use of HERTAB Lapatinib Tablets?

A: These tablets are primarily indicated for the treatment of HER2-positive breast cancer. Lapatinib, the active ingredient, acts as a targeted therapy, helping inhibit cancer cell growth in patients diagnosed with HER2-positive malignancies.

Q: When should the medication be stored and used to ensure its effectiveness?

A: HERTAB Lapatinib Tablets should be stored below 30C and kept protected from moisture. Always check the expiry date before useeach box provides a shelf life of up to 24 months from the manufacturing date to maintain product quality.

Q: Where can patients obtain HERTAB Lapatinib Tablets?

A: This prescription-only medication is available at authorized pharmacies, distributors, and through licensed healthcare providers in India. Always purchase from reputable sources to ensure authenticity and proper storage conditions.

Q: What are the main benefits of using HERTAB in breast cancer therapy?

A: HERTAB offers the benefit of targeted therapy, specifically addressing HER2-positive cancer cells. This targeted approach may enhance treatment efficacy and minimize unwanted effects on healthy tissues compared to more generalized cancer treatments.

Q: Who manufactures and supplies HERTAB Lapatinib Tablets?

A: HERTAB is manufactured and marketed by Hetero Healthcare. It is supplied across India and is accessible through distributors, exporters, suppliers, traders, and wholesalers.

Tell us about your requirement